Paclitaxel Medium/Long-chain Fat Emulsion (Cholesterol-Conjugated)

N/A

Report date: 2024/07/24 20:00:37

Base Information

Drug NamePaclitaxel Medium/Long-chain Fat Emulsion (Cholesterol-Conjugated)
Drug Alias NameWH002WH-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeijing Wehand-Bio Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversidad Católica San Antonio De Murcia
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A